Back to top
more

Elevance Health, Inc. (ELV)

(Real Time Quote from BATS)

$537.03 USD

537.03
242,999

-0.23 (-0.04%)

Updated Apr 29, 2024 12:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

HCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions

by Zacks Equity Research

HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.

Here's Why Elevance Health (ELV) is a Strong Momentum Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Industry Outlook Highlights Elevance Health Medpace and Doximity

by Zacks Equity Research

Elevance Health, Medpace and Doximity are part of the Zacks Industry Outlook article.

Community Health (CYH) Q1 Earnings Top on Better Occupancy Rates

by Zacks Equity Research

Community Health's (CYH) first-quarter results benefit from improved occupancy and reimbursement rates. However, declining admissions partially offset the positives.

Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership

by Zacks Equity Research

Molina Healthcare's (MOH) Q1 results reflect strong premium revenue growth. It continues to estimate adjusted EPS at a minimum of $23.50 for 2024.

Universal Health (UHS) Q1 Earnings Beat on Rising Patient Days

by Zacks Equity Research

Universal Health's (UHS) first-quarter results benefit from improved patient days in both segments. However, higher expenses partially offset the positives.

All You Need to Know About Elevance Health (ELV) Rating Upgrade to Buy

by Zacks Equity Research

Elevance Health (ELV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ELV or AVTR: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ELV vs. AVTR: Which Stock Is the Better Value Option?

Urmimala Biswas headshot

3 Medical Services Industry Stocks to Buy as Nursing Market Booms

by Urmimala Biswas

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most. However, staffing shortages continue to put brakes on growth.

Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Adlai Nortye Ltd. Sponsored ADR (ANL) and Elevance Health (ELV) have performed compared to their sector so far this year.

Why Elevance Health (ELV) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

The Zacks Analyst Blog Highlights Meta Platforms, Elevance Health, Canadian Natural Resources, The Coca-Cola and The Progressive

by Zacks Equity Research

Meta Platforms, Elevance Health, Canadian Natural Resources, The Coca-Cola and The Progressive are part of the Zacks top Analyst Blog

How Should You Play Centene (CNC) Ahead of Q1 Earnings?

by Zacks Equity Research

Centene's (CNC) first-quarter earnings are likely to reflect significant growth in commercial marketplace membership.

Sheraz Mian headshot

Top Research Reports for Meta Platforms, Elevance Health & Canadian Natural Resources

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Elevance Health, Inc. (ELV) and Canadian Natural Resources Limited (CNQ).

Why Elevance Health (ELV) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Elevance (ELV) Q1 Earnings Beat on Rate Hikes, Guidance Raised

by Zacks Equity Research

Elevance Health (ELV) has a leftover capacity of around $3.6 billion under its share buyback authorization.

Compared to Estimates, Elevance Health (ELV) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Elevance Health (ELV) Beats Q1 Earnings Estimates

by Zacks Equity Research

Elevance Health (ELV) delivered earnings and revenue surprises of 0.95% and 0.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Kaibalya Pravo Dey headshot

Is a Surprise Coming for Elevance (ELV) This Earnings Season?

by Kaibalya Pravo Dey

Elevance (ELV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Nalak Das headshot

5 Giants Likely to Win Big on Earnings Results This Week

by Nalak Das

We have narrowed our search to five large-cap stocks that are poised to beat on earnings results this week. These are: NFLX, ISRG, ELV, EFX, CSX.

Elevance Health (ELV), CD&R to Unveil Primary Care Offering

by Zacks Equity Research

Elevance Health (ELV) forms an alliance with CD&R to enhance primary care delivery by making collective use of the partners' assets and subsequently, reduce overall costs of care.

The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk, United Parcel Service, Booking and Elevance Health

by Zacks Equity Research

Microsoft, Novo Nordisk, United Parcel Service, Booking and Elevance Health are included in this Analyst Blog.

Will Elevance (ELV) Beat Q1 Earnings on Carelon Strength?

by Zacks Equity Research

The first-quarter results of Elevance (ELV) are likely to reflect higher product revenues and Commercial Individual membership growth.

Sheraz Mian headshot

Top Analyst Reports for Microsoft, Novo Nordisk & United Parcel

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Novo Nordisk A/S (NVO) and United Parcel Service, Inc. (UPS).

Medpace (MEDP) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.